{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T14:15:09Z","timestamp":1789395309240,"version":"build-2803163510"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2015,3,4]],"date-time":"2015-03-04T00:00:00Z","timestamp":1425427200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1007\/s12032-015-0548-4","type":"journal-article","created":{"date-parts":[[2015,3,3]],"date-time":"2015-03-03T04:57:07Z","timestamp":1425358627000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Increased Sushi repeat-containing protein X-linked 2 is associated with progression of colorectal cancer"],"prefix":"10.1007","volume":"32","author":[{"given":"K. L.","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. H.","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,3,4]]},"reference":[{"issue":"9927","key":"548_CR1","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1016\/S0140-6736(13)61649-9","volume":"383","author":"H Brenner","year":"2014","unstructured":"Brenner H, Kloor M, Pox CP. Colorectal cancer. Lancet. 2014;383(9927):1490\u2013502.","journal-title":"Lancet"},{"issue":"4","key":"548_CR2","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1083\/jcb.201102147","volume":"196","author":"PF Lu","year":"2012","unstructured":"Lu PF, Weaver VM, Werb Z, et al. The extracellular matrix: a dynamic niche in cancer progression. JCB. 2012;196(4):395\u2013406.","journal-title":"JCB"},{"issue":"6","key":"548_CR3","first-page":"983","volume":"3","author":"C Ricciardelli","year":"1997","unstructured":"Ricciardelli C, Mayne K, Sykes PJ, et al. Elevated stromal chondroitin sulfate glycosaminoglycan predicts progression in early-stage prostate cancer. Clin Cancer Res. 1997;3(6):983\u201392.","journal-title":"Clin Cancer Res"},{"issue":"4","key":"548_CR4","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1093\/jb\/mvj181","volume":"140","author":"P Pothacharoen","year":"2006","unstructured":"Pothacharoen P, Siriaunkgul S, Ong-Chai S, et al. Raised serum chondroitin sulfate epitope level in ovarian epithelial cancer. J Biochem. 2006;140(4):517\u201324.","journal-title":"J Biochem"},{"issue":"6","key":"548_CR5","doi-asserted-by":"crossref","first-page":"539","DOI":"10.3109\/00016348809029866","volume":"67","author":"EB Olsen","year":"1988","unstructured":"Olsen EB, Trier K, Eldov K, et al. Glycosaminoglycans in human breast cancer. Acta Obstet Gynecol Scand. 1988;67(6):539\u201342.","journal-title":"Acta Obstet Gynecol Scand"},{"key":"548_CR6","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1042\/BJ20061176","volume":"403","author":"J Iida","year":"2007","unstructured":"Iida J, Wilhelmson K, Ng J, et al. Cell surface chondroitin sulfate glycosaminoglycan in melanoma: role in the activation of pro-MMP-2 (pro-gelatinase A). Biochem J. 2007;403:553\u201363.","journal-title":"Biochem J"},{"issue":"1","key":"548_CR7","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s11060-014-1541-z","volume":"120","author":"CA Dwyer","year":"2014","unstructured":"Dwyer CA, Bi WL, Viapiano MS, et al. Brevican knockdown reduces late-stage glioma tumor aggressiveness. J Neurooncol. 2014;120(1):63\u201372.","journal-title":"J Neurooncol"},{"issue":"7","key":"548_CR8","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1093\/glycob\/cwp041","volume":"19","author":"Basappa","year":"2009","unstructured":"Basappa, Murugan S, Sugahara KN, et al. Involvement of chondroitin sulfate E in the liver tumor focal formation of murine osteosarcoma cells. Glycobiology. 2009;19(7):735\u201342.","journal-title":"Glycobiology"},{"issue":"30","key":"548_CR9","doi-asserted-by":"crossref","first-page":"3962","DOI":"10.3748\/wjg.v18.i30.3962","volume":"18","author":"XL Jia","year":"2012","unstructured":"Jia XL, Li SY, Dang SS, et al. Increased expression of chondroitin sulphate proteoglycans in rat hepatocellular carcinoma tissues. World J Gastroenterol. 2012;18(30):3962.","journal-title":"World J Gastroenterol"},{"issue":"Suppl 3","key":"548_CR10","doi-asserted-by":"crossref","first-page":"S348","DOI":"10.1245\/s10434-012-2441-0","volume":"20","author":"M Wit de","year":"2013","unstructured":"de Wit M, Belt EJ, Delis-van Diemen PM, et al. Lumican and versican are associated with good outcome in stage II and III colon cancer. Ann Surg Oncol. 2013;20(Suppl 3):S348\u201359.","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"548_CR11","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.jcpa.2004.04.007","volume":"131","author":"S Mukaratirwa","year":"2004","unstructured":"Mukaratirwa S, Van Ederen AM, Gruys E, et al. Versican and hyaluronan expression in canine colonic adenomas and carcinomas: relation to malignancy and depth of tumour invasion. J Comp Pathol. 2004;131(4):259\u201370.","journal-title":"J Comp Pathol"},{"issue":"2","key":"548_CR12","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.febslet.2012.11.023","volume":"587","author":"W Yang","year":"2013","unstructured":"Yang W, Yee AJ. Versican V2 isoform enhances angiogenesis by regulating endothelial cell activities and fibronectin expression. FEBS Lett. 2013;587(2):185\u201392.","journal-title":"FEBS Lett"},{"issue":"5","key":"548_CR13","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1158\/1541-7786.MCR-12-0461","volume":"11","author":"WW Du","year":"2013","unstructured":"Du WW, Fang L, Yang X, et al. The role of versican in modulating breast cancer cell self-renewal. Mol Cancer Res. 2013;11(5):443\u201355.","journal-title":"Mol Cancer Res"},{"issue":"1","key":"548_CR14","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1182\/blood.V93.1.321","volume":"93","author":"H Kurosawa","year":"1999","unstructured":"Kurosawa H, Goi K, Inukai T, et al. Two candidate downstream target genes for E2A-HLF. Blood. 1999;93(1):321\u201332.","journal-title":"Blood"},{"issue":"1","key":"548_CR15","doi-asserted-by":"crossref","first-page":"e27922","DOI":"10.1371\/journal.pone.0027922","volume":"7","author":"K Tanaka","year":"2012","unstructured":"Tanaka K, Arao T, Tamura D, et al. SRPX2 is a novel chondroitin sulfate proteoglycan that is overexpressed in gastrointestinal cancer. PLoS One. 2012;7(1):e27922.","journal-title":"PLoS One"},{"issue":"5","key":"548_CR16","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1002\/ijc.24065","volume":"124","author":"K Tanaka","year":"2009","unstructured":"Tanaka K, Arao T, Maegawa M, et al. SRPX2 is overexpressed in gastric cancer and promotes cellular migration and adhesion. Int J Cancer. 2009;124(5):1072\u201380.","journal-title":"Int J Cancer"},{"issue":"8","key":"548_CR17","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1002\/jso.23602","volume":"109","author":"T Yamada","year":"2014","unstructured":"Yamada T, Oshima T, Yoshihara K, et al. Impact of overexpression of Sushi repeat-containing protein X-linked 2 gene on outcomes of gastric cancer. J Surg Oncol. 2014;109(8):836\u201340.","journal-title":"J Surg Oncol"},{"issue":"10","key":"548_CR18","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1002\/ijc.27921","volume":"132","author":"B \u00d8ster","year":"2013","unstructured":"\u00d8ster B, Linnet L, Christensen LL, et al. Non-CpG island promoter hypomethylation and miR-149 regulate the expression of SRPX2 in colorectal cancer. Int J Cancer. 2013;132(10):2303\u201315.","journal-title":"Int J Cancer"},{"issue":"18","key":"548_CR19","first-page":"2553","volume":"22","author":"KL Liu","year":"2014","unstructured":"Liu KL, Zhou Y, Wu J. Construction of a eukaryotic vector expressing SRPX2 and its expression in cell line SW480. Shijie Huaren Xiaohua Zazhi. 2014;22(18):2553\u20138. doi: 10.11569\/wcjd.v22.i18.2553 (A Chinese Journal).","journal-title":"Shijie Huaren Xiaohua Zazhi"},{"issue":"23","key":"548_CR20","doi-asserted-by":"crossref","first-page":"3617","DOI":"10.1093\/hmg\/ddn256","volume":"17","author":"B Royer-Zemmour","year":"2008","unstructured":"Royer-Zemmour B, Ponsole-Lenfant M, Gara H, et al. Epileptic and developmental disorders of the speech cortex: ligand\/receptor interaction of wild-type and mutant SRPX2 with the plasminogen activator receptor uPAR. Hum Mol Genet. 2008;17(23):3617\u201330.","journal-title":"Hum Mol Genet"},{"issue":"12","key":"548_CR21","doi-asserted-by":"crossref","first-page":"4105","DOI":"10.1096\/fj.09-135202","volume":"23","author":"M Miljkovic-Licina","year":"2009","unstructured":"Miljkovic-Licina M, Hammel P, Garrido-Urbani S, et al. Sushi repeat protein X-linked 2, a novel mediator of angiogenesis. FASEB J. 2009;23(12):4105\u201316.","journal-title":"FASEB J"},{"issue":"2","key":"548_CR22","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1440-1827.2004.01593.x","volume":"54","author":"T Ishiwata","year":"2004","unstructured":"Ishiwata T, Fujii T, Ishiwata S, et al. Effect of morpholino antisense oligonucleotide against lumican mRNA in human embryonic kidney (HEK) 293 cells. Pathol Int. 2004;54(2):77\u201381.","journal-title":"Pathol Int"},{"issue":"2","key":"548_CR23","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/j.1742-4658.2007.06205.x","volume":"275","author":"D Nikitovic","year":"2008","unstructured":"Nikitovic D, Berdiaki A, Zafiropoulos A, et al. Lumican expression is positively correlated with the differentiation and negatively with the growth of human osteosarcoma cells. FEBS J. 2008;275(2):350\u201361.","journal-title":"FEBS J"},{"issue":"1","key":"548_CR24","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.canlet.2012.01.023","volume":"320","author":"T Yamamoto","year":"2012","unstructured":"Yamamoto T, Matsuda Y, Kawahara K, et al. Secreted 70\u00a0kDa lumican stimulates growth and inhibits invasion of human pancreatic cancer. Cancer Lett. 2012;320(1):31\u20139.","journal-title":"Cancer Lett"},{"issue":"2","key":"548_CR25","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.yexcr.2004.02.005","volume":"296","author":"B Vuillermoz","year":"2004","unstructured":"Vuillermoz B, Khoruzhenko A, D\u2019Onofrio MF, et al. The small leucine-rich proteoglycan lumican inhibits melanoma progression. Exp Cell Res. 2004;296(2):294\u2013306.","journal-title":"Exp Cell Res"},{"issue":"22","key":"548_CR26","doi-asserted-by":"crossref","first-page":"5023","DOI":"10.1111\/febs.12927","volume":"281","author":"AD Theocharis","year":"2014","unstructured":"Theocharis AD, Gialeli C, Bouris P, et al. Cell\u2013matrix interactions: focus on proteoglycan\u2013proteinase interplay and pharmacological targeting in cancer. FEBS J. 2014;281(22):5023\u201342.","journal-title":"FEBS J"},{"issue":"1","key":"548_CR27","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.cell.2010.03.015","volume":"141","author":"K Kessenbrock","year":"2010","unstructured":"Kessenbrock K, Plaks V, Werb Z. Matrix metalloproteinases: regulators of the tumor microenvironment. Cell. 2010;141(1):52\u201367.","journal-title":"Cell"},{"key":"548_CR28","doi-asserted-by":"crossref","unstructured":"Bhattacharyya S, Feferman L, Tobacman JK. Increased expression of colonic Wnt9A through Sp1-mediated transcriptional effects involving arylsulfatase B, chondroitin-4-sulfate, and galectin-3. J Biol Chem. 2014: jbc. M114. 561589.","DOI":"10.1074\/jbc.M114.561589"},{"issue":"8","key":"548_CR29","doi-asserted-by":"crossref","first-page":"e103966","DOI":"10.1371\/journal.pone.0103966","volume":"9","author":"CM Willis","year":"2014","unstructured":"Willis CM, Kl\u00fcppel M. Chondroitin sulfate-E is a negative regulator of a pro-tumorigenic Wnt\/beta-catenin-collagen 1 axis in breast cancer cells. PLoS One. 2014;9(8):e103966.","journal-title":"PLoS One"},{"issue":"4","key":"548_CR30","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.3892\/ol.2014.1828","volume":"7","author":"B Qu","year":"2014","unstructured":"Qu B, Liu BR, Du YJ, et al. Wnt\/\u03b2-catenin signaling pathway may regulate the expression of angiogenic growth factors in hepatocellular carcinoma. Oncol Lett. 2014;7(4):1175\u20138.","journal-title":"Oncol Lett"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-015-0548-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12032-015-0548-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-015-0548-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,30]],"date-time":"2020-08-30T12:34:58Z","timestamp":1598790898000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12032-015-0548-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,4]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["548"],"URL":"https:\/\/doi.org\/10.1007\/s12032-015-0548-4","relation":{},"ISSN":["1357-0560","1559-131X"],"issn-type":[{"value":"1357-0560","type":"print"},{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,4]]},"article-number":"99"}}